ReviewJournal of cheminformatics2026
Chemical space visualization at scale: a survey of end-to-end pipelines and dataset-size archetypes.
Review in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chemical space visualization supports exploration of high-dimensional molecular data by revealing patterns of similarity, diversity, and structure-property relationships. As chemical libraries expand from thousands to billions of compounds, practical visualization increasingly depends on pipelines that balance chemical meaning with computational and memory constraints. In this survey, we review 56 studies published between 2000 and 2025 and synthesize the end-to-end workflow of chemical space visualization across five core stages: dataset choice, molecular featurization, dimensionality reduction (DR), clustering, and evaluation. We quantify usage trends over time and relate method selection to dataset scale. Across the literature, fingerprints remain the dominant representation for large libraries due to their scalability, while recent studies increasingly incorporate fragments, SMILES-based encodings, and learned embeddings when richer signals are needed. DR practice shows a shift from PCA-centric baselines to neighborhood-preserving methods such as t-SNE and UMAP, with graph layout approaches like TMAP enabling visualization at extreme scale. Clustering shows the weakest convergence to a single standard: hierarchical methods, K-means, and SOM remain frequent choices, complemented by scalable summarization and domain-driven strategies (e.g., BIRCH/BitBIRCH and scaffold-based partitioning) when all-pairs similarity becomes prohibitive. Finally, we propose dataset-size-aware pipeline archetypes and identify open challenges, including inconsistent structure-aware evaluation, limited reproducibility reporting, and the need for scalable, chemically grounded methods for ultra-large libraries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.